Purple Biotech (PPBT) Intangibles (2017 - 2021)

Purple Biotech (PPBT) has disclosed Intangibles for 5 consecutive years, with $20.5 million as the latest value for Q4 2021.

  • On a quarterly basis, Intangibles changed 0.0% to $20.5 million in Q4 2021 year-over-year; TTM through Dec 2021 was $20.5 million, a 0.0% change, with the full-year FY2021 number at $20.5 million, changed 0.0% from a year prior.
  • Intangibles was $20.5 million for Q4 2021 at Purple Biotech, roughly flat from $20.5 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $20.5 million in Q4 2020 to a low of $6.2 million in Q4 2017.
  • A 5-year average of $11.9 million and a median of $6.2 million in 2017 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: changed 0.0% in 2018, then soared 231.85% in 2020.
  • Purple Biotech's Intangibles stood at $6.2 million in 2017, then changed by 0.0% to $6.2 million in 2018, then changed by 0.0% to $6.2 million in 2019, then skyrocketed by 231.85% to $20.5 million in 2020, then changed by 0.0% to $20.5 million in 2021.
  • Per Business Quant, the three most recent readings for PPBT's Intangibles are $20.5 million (Q4 2021), $20.5 million (Q4 2020), and $6.2 million (Q4 2019).